Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[idcc2006]

We got two news last week and today. Not two good news we have been waiting for but two bad ones. Accordingly the stock tanked further by 20%. Are they releasing bad ones first ahead of good ones?

I am not very hopeful for IND, but CTA seems to have a good chance, but who knows when. We have only one week left for the month and year, practically speaking.

No big partner interest is another disappointment considering the fact that this drug helped me big in 3 different symptoms. Do they think they can go around our IP rights?

As for CTA, shouldn't there be some party in UK or Europe to take care of clinical work there? Who's gonna do it? Already arranged or what?